Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC Q2056
    Short Description Ciltacabtagene car-pos t
    Long Description Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
    Pricing indicator 51
    Coverage code C
    ASC payment group code
    BETOS2 code O1D
    Action code N
    Type of service 1
    Effective date 2022-10-01
    Date Added 2022-10-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    57894011101 Q2056 Ciltacabtagene car-pos t Carvykti Janssen Biotech, Inc. up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells 1 1 1 1
    57894011102 Q2056 Ciltacabtagene car-pos t Carvykti Janssen Biotech, Inc. up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells 1 1 1 1
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].

    HCPCS Billing Calculator

    Dosage given to patient (per dose)
    HCPCS Dosage up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells
    HCPCS/CPT Billing Units 0.01
    Total doses ordered
    Billing Units 0.01